HIV News and Research

RSS

TAT-ARC fusion protein helps treat acute liver failure

Acute liver failure is a life-threatening disease, characterized by a sudden, massive death of liver cells. Unfortunately, few treatment options exist, especially for advanced-stage liver failure. As a last resort a liver transplant may be the only remaining option.

3 Aug 2012

Generic drugs saved U.S. $1T over 10 years, industry study finds

Generic drug makers released a study Thursday that found generic pharmaceuticals have saved the U.S. -- through private prescriptions as well as Medicare and Medicaid -- more than $1 trillion over 10 years.

3 Aug 2012

Investment in health systems 'a critical prerequisite' in beginning to end AIDS

The XIX International AIDS Conference (AIDS 2012) that took place last week in Washington, D.C., "ignited momentum to shift from 'fighting AIDS' to 'ending AIDS,'" Mohga Kamal-Yanni, senior health adviser at Oxfam International, and Urvarshi Rajcoomer, policy and advocacy adviser at Oxfam in South Africa, write in a Mail & Guardian opinion piece.

3 Aug 2012

Examining the role of economists in global health

In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at the center, reports on the contribution of economists to the global health field, writing, "Economists are not global health's most popular human resource.

3 Aug 2012

Birth control coverage mandate impacts doctors, women, religious groups

Physicians say they -- rather than insurers -- will feel the burden of the rule. Meanwhile, Republicans in Congress stay relatively quiet on the requirement, but tensions continue among Catholics and evangelical Protestants.

3 Aug 2012

Novel integrase inhibitor dolutegravir shows promise for HIV-1 treatment

The once-daily integrase inhibitor dolutegravir has shown promise in a phase III noninferiority study comparing it with twice-daily raltegravir for treatment of HIV-1, indicate study results presented at the 19th International AIDS Conference in Washington DC, USA.

3 Aug 2012

Mylan licenses rights to produce and market generic versions of Gilead HIV/AIDS therapies

Mylan Inc. today announced the establishment of a new agreement between its subsidiary Mylan Laboratories Limited and Gilead Sciences Inc. Under this agreement, Mylan has licensed the rights to produce and market generic versions of Gilead HIV/AIDS therapies containing Emtricitabine, including single and fixed-dose combinations.

3 Aug 2012

Change in drug policy needed to reverse HIV/AIDS epidemic in Eastern Europe, Central Asia

Noting the United Nations last week announced the appointment of Dr. Michel Kazatchkine, the former head of the Global Fund to Fight AIDS, Tuberculosis and Malaria, as the U.N. Secretary-General's new special envoy for HIV/AIDS in Eastern Europe and Central Asia," Kasia Malinowska-Sempruch, director of the Open Society Foundations' global drug policy program, writes in this Huffington Post opinion piece.

3 Aug 2012

PEPFAR announces $60M initiative to support implementation of science research, evaluation programs

PEPFAR on Wednesday "announced awards for a $60 million initiative, with potential for additional funding in year three, to support implementation science research and the evaluation of programs established under PEPFAR," according to a U.S. State Department media note.

3 Aug 2012

U.S. bipartisanship fundamental to continued progress against HIV/AIDS

"Health care, taxes, energy, favorite flavor of ice cream -- it seems our elected leaders must disagree at every turn. But one issue that has so far repulsed the partisan pressures of the times was highlighted at the XIX International AIDS Conference (AIDS 2012) in our nation's capital last week: the fight against HIV/AIDS," former Senate Majority Leader Bill Frist (R-Tenn.) writes in an opinion piece in "The Week."

2 Aug 2012

President Clinton delivers 'energizing call to action' at AIDS 2012 closing session

"Former President Bill Clinton delivered an energizing 'call to action' at the closing session of [the XIX International AIDS Conference (AIDS 2012)], encapsulating the high hopes and the sobering challenges facing the fight against global HIV/AIDS," Janet Fleischman, a senior associate at the Center for Strategic & International Studies' (CSIS) Global Health Policy Center, writes in the center's "Smart Global Health" blog.

2 Aug 2012

U.N. SG Ban names 26 members to high-level advisory panel for development agenda

U.N. Secretary-General Ban Ki-moon on Tuesday "announced the members of a High-level Panel to advise on the global development agenda beyond 2015, the target date for achieving the anti-poverty targets known as the Millennium Development Goals (MDGs)," the U.N. News Centre reports.

2 Aug 2012

HIV people with high CD4 counts could work more hours per week

In a first-of-its-kind health campaign in Uganda, researchers from the University of North Carolina at Chapel Hill show that adults with HIV who had less severe infections could work more hours per week, and their children were more likely to be enrolled in school.

1 Aug 2012

IRIN examines HIV prevention efforts among IDUs in Thailand

IRIN reports on HIV prevention efforts aimed at injecting drug users (IDUs) in Thailand, noting HIV prevalence among Thai IDUs is "among the highest in the Southeast Asia region, according to the Global AIDS Response progress report by" UNAIDS.

1 Aug 2012

Devex assesses HIV/AIDS funding, initiatives of 5 leading donor countries in 2011

Highlighting a recently released UNAIDS and Kaiser Family Foundation report (.pdf) on the financing of the global response to HIV/AIDS in low- and middle-income countries in 2011, Devex assesses the HIV/AIDS initiatives and funding levels of the five leading donor governments for that year.

1 Aug 2012

ART resistance increasing in sub-Saharan Africa

The prevalence of antiretroviral drug resistance is on the rise in sub-Saharan Africa, an increase driven by resistance to non-nucleoside reverse transcriptase inhibitors in east and southern Africa, research shows.

1 Aug 2012

HIV would 'remain a threat' even if world achieved 'AIDS-free generation' by any definition

Lawrence Altman, former senior medical correspondent for the New York Times, writes in an opinion analysis in the newspaper that while there was much discussion about "ending the AIDS epidemic" and an "AIDS-free generation" at the XIX International AIDS Conference (AIDS 2012) last week in Washington, D.C., "[o]ne obstacle is a failure to clearly define the epidemic or what it means to have an AIDS-free generation."

1 Aug 2012

Study: 150 million adults suffer from sleep-related problems across developing world

Levels of sleep problems in the developing world are approaching those seen in developed nations, linked to an increase in problems like depression and anxiety.

1 Aug 2012

Guardian's Boseley says USAID's Shah concerned about Europe's commitment to global health issues

In her "Global Health Blog," Guardian health editor Sarah Boseley notes that she spoke with USAID Administrator Rajiv Shah during last week's XIX International AIDS Conference (AIDS 2012).

1 Aug 2012

Namibian High Court rules HIV-positive women were improperly counseled before sterilization procedures, but not based on HIV status

"The Namibian High Court has ruled that the human rights of three HIV-positive women were violated when they were coerced into being sterilized while they gave birth, but the judge dismissed claims that the sterilization amounted to discrimination based on their HIV status," PlusNews reports.

1 Aug 2012

HIV News and Research

TAT-ARC fusion protein helps treat acute liver failure

Generic drugs saved U.S. $1T over 10 years, industry study finds

Investment in health systems 'a critical prerequisite' in beginning to end AIDS

Examining the role of economists in global health

Birth control coverage mandate impacts doctors, women, religious groups

Novel integrase inhibitor dolutegravir shows promise for HIV-1 treatment

Mylan licenses rights to produce and market generic versions of Gilead HIV/AIDS therapies

Change in drug policy needed to reverse HIV/AIDS epidemic in Eastern Europe, Central Asia

PEPFAR announces $60M initiative to support implementation of science research, evaluation programs

U.S. bipartisanship fundamental to continued progress against HIV/AIDS

President Clinton delivers 'energizing call to action' at AIDS 2012 closing session

U.N. SG Ban names 26 members to high-level advisory panel for development agenda

HIV people with high CD4 counts could work more hours per week

IRIN examines HIV prevention efforts among IDUs in Thailand

Devex assesses HIV/AIDS funding, initiatives of 5 leading donor countries in 2011

ART resistance increasing in sub-Saharan Africa

HIV would 'remain a threat' even if world achieved 'AIDS-free generation' by any definition

Study: 150 million adults suffer from sleep-related problems across developing world

Guardian's Boseley says USAID's Shah concerned about Europe's commitment to global health issues

Namibian High Court rules HIV-positive women were improperly counseled before sterilization procedures, but not based on HIV status

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News